UV Medico
Nicolas Volet is an Associate Professor at Aarhus University since 2019, previously holding the position of Tenure-Track Assistant Professor. Nicolas co-founded UVLaser in January 2022 and has been part of the IEEE Photonics Society as an Associate Editor for the IEEE Journal of Quantum Electronics since November 2023. In August 2023, Nicolas started lecturing at École polytechnique fédérale de Lausanne and has served as Co-Founder and Chief Technology Officer at UV Medico since 2020. Nicolas held the role of Senior R&D Engineer at OE Solutions from 2018 to 2019 and was a post-doctoral researcher at UC Santa Barbara from 2015 to 2018. Earlier positions included an academic guest at École polytechnique fédérale de Lausanne in 2014 and a doctoral assistant there from 2009 to 2013, working in the Laboratory of the Physics of Nanostructures. Nicolas also gained research experience as a research assistant at the University of Houston from 2008 to 2009. Educational qualifications include a Ph.D. in Physics, a Master’s degree in Physics, and a Bachelor’s degree in Physics from École polytechnique fédérale de Lausanne, alongside early studies at Carnegie Mellon University.
This person is not in any teams
UV Medico
In UV Medico, we are a team of scientists, experts and pioneers who are passionate about using far-UVC light to prevent viruses, bacteria, and other pathogens from affecting our society. As a result, we have launched the first non-harmful filtered far-UVC lamp on the market, UV222™. UV222™ is designed to emit far-UVC light at a particular wavelength of 222 nanometers. Previously, when a far-UVC lamp was designed to emit far-UVC light of 222 nanometers, the lamp would inevitably emit small amounts of secondary emission in other wavelengths as well. These wavelengths can be harmful. Our unique and patented safety filter technology blocks all the harmful and unwanted wavelengths from emission, which is a significant breakthrough for the disinfection of occupied spaces, highly increasing its effectiveness and usability against the spreading of infectious diseases, including COVID-19 (SARS-CoV-2).